SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-444094
Filing Date
2012-10-31
Accepted
2012-10-31 17:13:59
Documents
2
Period of Report
2012-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d428516d8k.htm 8-K 17914
2 SETTLEMENT AGREEMENT AND FULL AND FINAL RELEASE OF CLAIMS d428516dex101.htm EX-10.1 27855
  Complete submission text file 0001193125-12-444094.txt   47060
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 121171492
SIC: 2834 Pharmaceutical Preparations